{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-005267","form_type":"8-K","ticker":"INBS","cik":"0001725430","company_name":"INTELLIGENT BIO SOLUTIONS INC.","filed_at":"2024-02-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.271275+00:00","generated_at":"2026-06-06T07:07:18.064048+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"INBS raises $1.77M via Series E warrant exercise; issues Series G warrants at $4.50","bullets":["Existing warrant holders exercised 606,064 shares at $2.9232 for gross proceeds of ~$1.77M.","Holders receive one Series G warrant per exercised warrant, exercisable at $4.50 for 5.5 years.","Company to use net proceeds for working capital and general corporate purposes.","Ladenburg Thalmann acted as placement agent; fees include 8% cash fee and 5% warrant coverage.","Resale registration statement for Series G shares must be filed within 30 days."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-005267","json":"https://secwatch.observer/filing/0001493152-24-005267.json","markdown":"https://secwatch.observer/filing/0001493152-24-005267.md","text":"https://secwatch.observer/filing/0001493152-24-005267.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725430/000149315224005267/0001493152-24-005267-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725430/000149315224005267/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T07:07:18.064048+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"86ea6379872ca071118cea8d17f361858a9ee930","claim":"INTELLIGENT BIO SOLUTIONS INC. entered into Agreements with certain accredited and institutional holders valued at approximately $1.77 million (effective 2024-02-04).","evidence_excerpt":"On February 4, 2024, Intelligent Bio Solutions Inc. (the “Company”) entered into warrant inducement agreements (the “Agreements”) with certain accredited and institutional holders (collectively, the “Holders”) of the Company’s outstanding Series E Warrants issued on October 4, 2023","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1725430/000149315224005267/0001493152-24-005267-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain accredited and institutional holders"},{"label":"Value","value":"approximately $1.77 million"},{"label":"Effective","value":"2024-02-04"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}